Compass Therapeutics (CMPX) Interest Coverage Ratio (2018 - 2021)

Compass Therapeutics has reported Interest Coverage Ratio for 9 years, with the latest figure at 0.63 in Q1 2026.

• Quarterly Interest Coverage Ratio rose 92.53% year-over-year to 0.63 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 2.31 (up 91.96% YoY) and the FY2025 annual result came in at 0.92, up 3.36% from the prior year.
• Interest Coverage Ratio rose to 0.63 in Q1 2026 per CMPX's latest filing, from 179.9 in the prior quarter.
• Over five years, Interest Coverage Ratio peaked at 0.63 in Q1 2026 and troughed at 179.9 in Q4 2025.
• A 5-year average of 49.87 and a median of 22.15 in 2022 frame the typical range for Interest Coverage Ratio.
• The sharpest annual moves came in 2024 and 2025: Interest Coverage Ratio sank 2700.98% in 2024, then jumped 98.02% in 2025.
• Over 5 years, Interest Coverage Ratio stood at 42.96 in 2022, then tumbled by 258.31% to 153.93 in 2023, then jumped by 95.58% to 6.8 in 2024, then plunged by 2545.8% to 179.9 in 2025, then jumped by 99.65% to 0.63 in 2026.
• According to Business Quant data, Interest Coverage Ratio over the past three periods registered 0.63, 179.9, and 1.36 for Q1 2026, Q4 2025, and Q3 2025 respectively.